免疫营养改善肿瘤患者预后

doi:10.3969/j.issn.1006-7795.2020.06.027

首都医科大学学报 ›› 2020, Vol. 41 ›› Issue (6): 1019-1024.doi: 10.3969/j.issn.1006-7795.2020.06.027

免疫营养改善肿瘤患者预后

王欣¹, 张俊璇², 高健³, 石汉平^1,3*

1.首都医科大学附属北京世纪坛医院胃肠外科二病区,北京 100038;
2.承德医学院第二临床学院消化内科,河北承德 067000;
3.首都医科大学附属北京世纪坛医院临床营养科,北京 100038

收稿日期:2020-07-02 出版日期:2020-12-21 发布日期:2021-01-18
基金资助:
国家自然科学基金(81672888),国家重点研发计划项目(2017YFC1309200)。

Immunonutrition improves the prognosis of patients with cancer

Wang Xin¹, Zhang Junxuan², Gao Jian³, Shi Hanping^1,3*

1. Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China;
2. Department of Gastroenterology, Second Clinical College, Chengde Medical College, Chengde 067000, Hebei Province, China;
3. Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China

Received:2020-07-02 Online:2020-12-21 Published:2021-01-18
Contact: * E-mail:shihp@ccum.edu.cn
Supported by:
National Natural Science Foundation of China (81672888), National Key Research and Development Program of China (2017YFC1309200).

摘要/Abstract

摘要： 营养支持已不再是肿瘤的辅助治疗手段,而是能够改善患者预后,延长患者寿命的一线治疗方式。许多研究显示营养物质不仅为患者提供必要的能量基础,有些营养制剂更是可以通过调节机体免疫来抑制肿瘤细胞,预防癌症。本文将紧扣“肿瘤免疫”的主题,列举营养治疗成功的实例,如饮食模式、氨基酸、Ω-3多不饱和脂肪酸、微量元素、维生素、膳食纤维、益生菌等,着重分析营养物质通过调节机体免疫来影响肿瘤的生长、分化、自噬、凋亡等。“免疫营养”术语的提出,让医生考虑更好地设计和优化膳食免疫调节剂的组合和效能,为新型膳食成分和饮食产生的免疫调节机制的探索提供了新的方向。

关键词: 营养, 饮食, 肿瘤免疫, 预后, 癌症风险, 膳食炎症指数

Abstract: At present, nutritional support is no longer an adjuvant treatment for cancer, but a first-line treatment that can improve the prognosis of patients and prolong their lifespan. Many studies believe that nutrients not only provide patients with the essential energy, but some nutritional preparations can inhibit tumor cells and prevent carcinogenesis by regulating immunity. However, the mechanism is not entirely clear. This review closely followed the theme of “tumor immunity” and list some examples of successful nutritional treatments, such as diet patterns, amino acids, omega-3 polyunsaturated fatty acids, trace elements, vitamins, dietary fiber, and probiotics, etc. This review also analyzed that nutrients affect the growth, differentiation, autophagy, apoptosis of tumors by regulating the body's immunity. The term “immune nutrition” allows us to consider the concept of a dietary immune index for better designing and optimizing the combination and efficacy of dietary immune modulators, and thus to provide a new direction to explore the new dietary components and mechanisms of immune regulation.

Key words: nutrition, diet, tumor immunity, prognosis, cancer risk, dietary inflammation index

中图分类号:

王欣, 张俊璇, 高健, 石汉平. 免疫营养改善肿瘤患者预后[J]. 首都医科大学学报, 2020, 41(6): 1019-1024.

Wang Xin, Zhang Junxuan, Gao Jian, Shi Hanping. Immunonutrition improves the prognosis of patients with cancer[J]. Journal of Capital Medical University, 2020, 41(6): 1019-1024.

参考文献

[1] Mittal D, Gubin M M, Schreiber R D, et al. New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape[J]. Curr Opin Immunol, 2014, 27:16-25.
[2] Krysko D V, Garg A D, Kaczmarek A, et al. Immunogenic cell death and DAMPs in cancer therapy[J]. Nat Rev Cancer, 2012, 12(12):860-875.
[3] Galluzzi L, Buque A, Kepp O, et al. Immunological effects of conventional chemotherapy and targeted anticancer agents[J]. Cancer Cell,2015, 28(6):690-714.
[4] Sharma P, Allison J P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential[J]. Cell, 2015, 161(2):205-214.
[5] Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer[J]. Nat Immunol, 2017, 18:843-850.
[6] van Niekerk G, Loos B, Nell T, et al. Autophagy—a free meal in sickness-associated anorexia[J]. Autophagy, 2016, 12(4):727-734.
[7] Wei M, Brandhorst S, Shelehchi M, et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease[J]. Sci Transl Med, 2017, 9(377): eai8700
[8] Puchalska P, Crawford P A. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics[J]. Cell Metab, 2017, 25(2):262-284.
[9] Wang A, Huen S C, Luan H H, et al. Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation[J]. Cell,2016, 166(6):1512-1525.e1512.
[10]Lee S H, Min K J. Caloric restriction and its mimetics[J]. BMB Rep, 2013, 46(4):181-187.
[11]Janakiram N B, Mohammed A, Madka V, et al. Prevention and treatment of cancers by immune modulating nutrients[J]. Mol Nutr Food Res, 2016, 60(6):1275-1294.
[12]Lamas B, Vergnaud-Gauduchon J, Goncalves-Mendes N, et al. Altered functions of natural killer cells in response to L-Arginine availability[J]. Cell Immunol, 2012, 280(2):182-190.
[13]Norian L A, Rodriguez P C, O′Mara L A, et al. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism[J]. Cancer Res, 2009, 69(7):3086-3094.
[14]Ochoa A C, Zea A H, Hernandez C, et al. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma[J]. Clin Cancer Res, 2007, 13(2 Pt 2):721s-726s.
[15]陈峰,郑晓红,李文斌.脑胶质瘤免疫治疗进展[J].首都医科大学学报,2019,40(6):966-971.
[16]黎可人,孙诚谊.肝癌的免疫治疗进展[J].中华肿瘤防治杂志,2018,25(17):1266-1270.
[17]Hansen A M, Caspi R R. Glutamate joins the ranks of immunomodulators[J]. Nat Med, 2010, 16(8):856-858.
[18]Fallarino F, Volpi C, Fazio F, et al. Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation[J]. Nat Med, 2010, 16(8):897-902.
[19]Kuhn K S, Muscaritoli M, Wischmeyer P, et al. Glutamine as indispensable nutrient in oncology: experimental and clinical evidence[J]. Eur J Nutr, 2010, 49(4):197-210.
[20]Elinav E, Nowarski R, Thaiss C A, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms[J]. Nat Rev Cancer, 2013, 13(11):759-771.
[21]Facciabene A, Motz G T, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis[J]. Cancer Res, 2012, 72(2):2162-2171.
[22]Song M, Nishihara R, Cao Y, et al. Marine omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer characterized by tumor-infiltrating T cells[J]. JAMA Oncol, 2016, 2(9):1197-1206.
[23]Manning J, Mitchell B, Appadurai D A, et al. Vitamin C promotes maturation of T-cells[J]. Antioxid Redox Signal, 2013, 19(17):2054-2067.
[24]Jubri Z, Latif A A, Top A G, et al. Perturbation of cellular immune functions in cigarette smokers and protection by palm oil vitamin E supplementation[J]. Nutr J, 2013, 12:2.
[25]Song M, Chan A T. Diet, gut microbiota, and colorectal cancer prevention: a review of potential mechanisms and promising targets for future research[J]. Curr Colorectal Cancer Rep, 2017, 13(6):429-439.
[26]Zheng H, Zhao W, Yan C, et al. HDAC inhibitors enhance T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma[J]. Clin Cancer Res, 2016, 22(16):4119-4132.
[27]Song M, Chan A T. The potential role of exercise and nutrition in harnessing the immune system to improve colorectal cancer survival[J]. Gastroenterology, 2018, 155(3):596-600.
[28]Bonaventura P, Benedetti G, Albarede F, et al. Zinc and its role in immunity and inflammation[J]. Autoimmun Rev, 2015, 14(4):277-285.
[29]Li P, Xu J, Shi Y, et al. Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis[J]. Clin Nutr, 2014, 33(3):415-420.
[30]Tsuji P A, Carlson B A, Anderson C B, et al. Dietary selenium levels affect selenoprotein expression and support the interferon-gamma and IL-6 immune response pathways in mice[J]. Nutrients, 2015, 7(8):6529-6549.
[31]Wood S M, Beckham C, Yosioka A, et al. beta-Carotene and selenium supplementation enhances immune response in aged humans[J]. Integr Med, 2000, 2(2):85-92.
[32]Sivan A, Corrales L, Hubert N, et al. Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy[J]. Science, 2015, 350(6264):1084-1089.
[33]Lopez P, Gueimonde M, Margolles A, et al. Distinct bifidobacterium strains drive different immune responses in vitro[J]. Int J Food Microbiol, 2010, 138(1-2):157-165.
[34]Hebert J R, Shivappa N, Wirth M D, et al. Perspective: the dietary inflammatory index (DII)-lessons learned, improvements made, and future directions[J]. Adv Nutr, 2019, 10:185-195.

免疫营养改善肿瘤患者预后

Immunonutrition improves the prognosis of patients with cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王荣荣, 田俊萍. 急性冠脉综合征患者血清钙与心血管预后的关系[J]. 首都医科大学学报, 2023, 44(1): 154-160.
[2]	贾静, 陈文明, 李燕郴. 多发性骨髓瘤伴中枢侵犯临床特征及预后分析[J]. 首都医科大学学报, 2023, 44(1): 161-166.
[3]	于天宇, 姜世敏, 高红梅, 邹古明, 李文歌. 糖尿病肾病慢性肾脏病4期患者肾脏临床及病理因素与预后的关系[J]. 首都医科大学学报, 2022, 43(5): 707-712.
[4]	郭康林, 程一春, 葛树旺, 徐钢. IgA肾病国际风险预测工具在中国人群中的预测效果评价[J]. 首都医科大学学报, 2022, 43(5): 713-719.
[5]	谷强, 余孝君, 张津. 高龄与中低龄老年轻型缺血性脑卒中临床特点及预后分析[J]. 首都医科大学学报, 2022, 43(3): 474-479.
[6]	周巧云, 黄晓武, 夏恩兰, 赵玉婷, 黄睿. 子宫动脉栓塞后宫腔粘连的生殖结局分析[J]. 首都医科大学学报, 2022, 43(3): 490-494.
[7]	苗祖霈, 张迎花, 肖克令, 司瑾, 张浩宇, 李静. 肥胖程度对急性ST段抬高型心肌梗死患者预后的影响[J]. 首都医科大学学报, 2022, 43(2): 192-198.
[8]	孙丛丛, 吴涵, 周丹娜, 姜玮, 王雯, 杨春林, 马辛, 任艳萍. 脑源性神经营养因子对经颅磁刺激治疗难治性抑郁症的疗效预测作用[J]. 首都医科大学学报, 2022, 43(2): 227-232.
[9]	孙婧, 史幼梧, 贾军, 杨颖, 孙志伟, 杜丰, 余靖, 肖艳洁, 张晓东. 血液炎症相关指标在晚期胰腺癌中的预后价值[J]. 首都医科大学学报, 2022, 43(2): 299-304.
[10]	杨柳青, 田红梅, 石汉平. 三种饮食模式与慢性疾病研究进展[J]. 首都医科大学学报, 2022, 43(2): 311-320.
[11]	高明, 周营利, 朱研, 秦君平, 黄惠斌, 任昱, 谈莉, 周华, 许媛. 重症患者急性期能量平衡对住院期间死亡的影响[J]. 首都医科大学学报, 2021, 42(6): 931-935.
[12]	李健, 白文佩, 江波, 白栎然, 吴凤云. 生酮饮食对超重/肥胖多囊卵巢综合征女性月经及生育力的影响[J]. 首都医科大学学报, 2021, 42(6): 1021-1025.
[13]	刘洋, 吴玉梅, 何玥, 樊蓓, 王雁, 赵辉, 王明. ⅠB期子宫颈癌国际妇产科联盟2018新分期的合理性验证及评估[J]. 首都医科大学学报, 2021, 42(6): 1026-1032.
[14]	王莉, 张国军. 血清神经元特异性烯醇化酶与外伤性脑损伤患者及临床特征的关系[J]. 首都医科大学学报, 2021, 42(5): 715-720.
[15]	来璇, 张爱华. 代谢综合征对慢性肾脏病患者生存预后的影响[J]. 首都医科大学学报, 2021, 42(4): 609-614.